End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.33 MYR | -0.85% |
|
-0.85% | -1.27% |
May. 29 | Genetec Technology's Profit Jumps in March Quarter; Shares Rise 5% | MT |
May. 28 | Genetec Technology Berhad Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Valuation
Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 194 | 1,719 | 2,025 | 1,806 | - | - |
Enterprise Value (EV) 1 | 194 | 1,781 | 1,896 | 1,806 | 1,806 | 1,806 |
P/E ratio | -43.7 x | 31.9 x | 26.6 x | 17.9 x | 15.5 x | 12.9 x |
Yield | - | - | - | 0.86% | 0.94% | 1.12% |
Capitalization / Revenue | 2 x | 7.69 x | 6.59 x | 4.3 x | 3.73 x | 3.24 x |
EV / Revenue | 2 x | 7.69 x | 6.59 x | 4.3 x | 3.73 x | 3.24 x |
EV / EBITDA | - | 25.6 x | 23.3 x | 14.6 x | 12.3 x | 10.4 x |
EV / FCF | - | -16 x | 130 x | 34.5 x | 22.1 x | 17.1 x |
FCF Yield | - | -6.27% | 0.77% | 2.9% | 4.53% | 5.84% |
Price to Book | - | 11.5 x | 5 x | 3.58 x | 2.99 x | 2.53 x |
Nbr of stocks (in thousands) | 593,311 | 681,962 | 750,158 | 775,131 | - | - |
Reference price 2 | 0.3269 | 2.520 | 2.700 | 2.330 | 2.330 | 2.330 |
Announcement Date | 7/29/21 | 5/26/22 | 5/31/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net sales 1 | 97.08 | 223.6 | 307.4 | 419.9 | 484.7 | 557.5 |
EBITDA 1 | - | 67.2 | 86.87 | 123.9 | 146.3 | 174.3 |
EBIT 1 | - | 63.93 | 83.32 | 112.1 | 131.8 | 158.5 |
Operating Margin | - | 28.59% | 27.1% | 26.7% | 27.19% | 28.43% |
Earnings before Tax (EBT) 1 | - | 62.29 | 80.3 | 110.5 | 131.3 | 159.5 |
Net income 1 | - | 56.4 | 73.4 | 100.2 | 109.1 | 131.3 |
Net margin | - | 25.23% | 23.88% | 23.86% | 22.51% | 23.55% |
EPS 2 | -0.007480 | 0.0790 | 0.1015 | 0.1300 | 0.1500 | 0.1800 |
Free Cash Flow 1 | - | -107.7 | 15.58 | 52.4 | 81.8 | 105.4 |
FCF margin | - | -48.19% | 5.07% | 12.48% | 16.88% | 18.91% |
FCF Conversion (EBITDA) | - | - | 17.93% | 42.29% | 55.91% | 60.47% |
FCF Conversion (Net income) | - | - | 21.22% | 52.3% | 74.98% | 80.27% |
Dividend per Share 2 | - | - | - | 0.0200 | 0.0220 | 0.0260 |
Announcement Date | 7/29/21 | 5/26/22 | 5/31/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: March | 2024 Q3 |
---|---|
Net sales 1 | 70.47 |
EBITDA | - |
EBIT | - |
Operating Margin | - |
Earnings before Tax (EBT) | - |
Net income 1 | 16.84 |
Net margin | 23.9% |
EPS 2 | 2.180 |
Dividend per Share | - |
Announcement Date | 5/28/24 |
Balance Sheet Analysis
Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net Debt | - | 62.6 | - | - | - | - |
Net Cash position | - | - | 130 | - | - | - |
Leverage (Debt/EBITDA) | - | 0.932 x | - | - | - | - |
Free Cash Flow 1 | - | -108 | 15.6 | 52.4 | 81.8 | 105 |
ROE (net income / shareholders' equity) | - | 49% | 26.4% | 23.2% | 20.2% | - |
ROA (Net income/ Total Assets) | - | 27% | 18.1% | - | - | - |
Assets 1 | - | 209.3 | 405.7 | - | - | - |
Book Value Per Share 2 | - | 0.2200 | 0.5400 | 0.6500 | 0.7800 | 0.9200 |
Cash Flow per Share | - | -0.1400 | 0.1300 | - | - | - |
Capex | - | 8.13 | 76.8 | - | - | - |
Capex / Sales | - | 3.64% | 24.98% | - | - | - |
Announcement Date | 7/29/21 | 5/26/22 | 5/31/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.27% | 386M | |
+12.76% | 88.04B | |
+23.44% | 73.1B | |
+29.74% | 40.48B | |
+23.52% | 34.25B | |
+7.18% | 27.78B | |
+10.18% | 27.2B | |
-1.38% | 25.62B | |
+24.50% | 26.32B | |
+7.47% | 22.4B |
- Stock Market
- Equities
- GENETEC Stock
- Financials Genetec Technology